I-PreFer Study: A Questionnaire to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Treatment Options.

Hollmen, Maria; Bromilow, Tom; Smith, Adam B; Mealing, Stuart; Lewis, Damian; Galvin, Liam; Jones, Steve; Pacheco, Luís; Soulard, Stéphane; Froidure, Antoine

Hollmen, Maria; Bromilow, Tom; Smith, Adam B; Mealing, Stuart; Lewis, Damian; Galvin, Liam; Jones, Steve; Pacheco, Luís; Soulard, Stéphane; Froidure, Antoine.

Afiliación

Hollmen M; Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Bromilow T; York Health Economics Consortium (YHEC), York, UK.
Smith AB; York Health Economics Consortium (YHEC), York, UK.
Mealing S; York Health Economics Consortium (YHEC), York, UK.
Lewis D; York Health Economics Consortium (YHEC), York, UK.
Galvin L; European Pulmonary Fibrosis & Related Disorders Federation, Overijse, Belgium.
Jones S; European Pulmonary Fibrosis & Related Disorders Federation, Overijse, Belgium.
Pacheco L; Boehringer Ingelheim, Amsterdam, the Netherlands.
Soulard S; Boehringer Ingelheim, Amsterdam, the Netherlands.
Froidure A; Service de Pneumologie, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Patient Prefer Adherence ; 17: 1621-1639, 2023.

Article en En | MEDLINE | ID: mdl-37560148

Palabras clave

adherence; antifibrotic; behavior; lung disease; online survey; outcomes research

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Qualitative_research Idioma: En Revista: Patient Prefer Adherence Año: 2023 Tipo del documento: Article País de afiliación: Finlandia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google